Navigation Links
China Kangtai Cactus Biotech Q2 Revenue Up 30% to Record $6.5M; Net Income Up 37% to $1.4M, EPS $0.07

HARBIN, China, Aug. 13 /PRNewswire-Asia-FirstCall/ -- China Kangtai Cactus Biotech Inc. (OTC Bulletin Board: CKGT), a vertically integrated grower, developer, manufacturer, and marketer of a variety of cactus-based products in China, announced today that revenue for the second quarter of 2009 increased 30% to $6.5 million from $5.0 million in the second quarter of 2008. Diluted earnings per share for the quarter was $0.07 based on a net income of $1.4 million, compared to a net income of $1.0 million or $0.06 diluted EPS last year.

    Second Quarter Highlights

    -- Second quarter revenue increased 30% to $6.5 million from $5.0 million
       in Q2 2008
    -- On a sequential basis, Q2 revenue increased 96% from $3.3 million in Q1
    -- Cash and cash equivalents totaled $2.8 million, an increase of 19% from
       $2.3 million as of March 31, 2009
    -- Gross profit increased 80% to $2.7 million from $1.5 million in Q2 2008
    -- Sequentially, gross profit increased 121% from 1.2 million in Q1, 2009
    -- Gross margins were 42%, up from 30% reported in Q2 2008 and 37% in Q1
    -- Net income increased 37% to $1.4 million from $1.0 million in Q2 2008
    -- Sequentially, net income experienced a 105% increase from $694,000 in
       Q1 2009

For the first six months of 2009, revenue was $9.8 million, an increase of 27% from $7.8 million for the comparable period last year. Net income for the first six months of 2009 was up 29% at $2.1 million, compared to $1.6 million for the first six months of 2008.

China Kangtai CEO Jinjiang Wang said, "The pace of our revenue growth accelerated in the second quarter with a year-over-year increase of 30% and a sequential increase of 96%. This was primarily driven by growing acceptance of our cactus-derived products. The increase in consumer consumption, led by Kangtai's expanding brand awareness, indicates a bright future for our health and wellness products, including nutraceuticals, nutritional food and drinks, and animal feed products. We expect continued improvement throughout the second half of 2009 as we focus our integration efforts on the March acquisition to further expand our production and distribution capacity."

In March, the company acquired the assets of Qitaihe Kangwei Biotechnology Co., Ltd. The purchase included the right to use 49,000 square meters of state-owned land in Qitaihe City, as well as housing, machinery, equipment, and related facilities. The purchase price was approximately $5.42 million.

About China Kangtai Cactus Biotech, Inc.

China Kangtai Cactus Biotech, Inc. is a leading grower, developer, producer, and marketer of cactus-derived products, including nutraceuticals, nutritious food, health and energy drinks, beer, wine and liquor, extracts and powders, and animal feed. China Kangtai controls over 387 acres of plants and maintains an active R&D group that holds 18 product patents and is seeking another 12. China Kangtai's high-quality "green" products are sold throughout China via a distribution network that covers 12 of China's 23 provinces and two of China's four municipalities. More information may be found at or via e-mail: .

An investment profile on China Kangtai Cactus Biotech Inc. is available at . For an online investor relations kit, visit . For more investor-related questions, contact Susan Zhou, Hawk Associates, at 305-451-1888, e-mail: . To subscribe to future releases via e-mail alert, visit .

This news release contains forward-looking statements as defined by the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, future events or performance, and underlying assumptions and other statements that are other than statements of historical facts. These statements are subject to uncertainties and risks including, but not limited to, product and service demand and acceptance, changes in technology, economic conditions, the impact of competition and pricing, government regulation, and other risks contained in reports filed by the company with the Securities and Exchange Commission. All such forward-looking statements, whether written or oral, and whether made by or on behalf of the company, are expressly qualified by the cautionary statements and any other cautionary statements which may accompany the forward-looking statements. In addition, the company disclaims any obligation to update any forward-looking statements to reflect events or circumstances after the date hereof.

    For more information, please contact:

    Hawk Associates
     Susan Zhou
     Tel:   +1-305-451-1888

SOURCE China Kangtai Cactus Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Chinas 1-child policy could backfire on its elderly
2. Omnicom Acquires Leading Healthcare Marketing Communications Firm in China
3. Expanding Prevalent Population Will Drive Dramatic Growth for the Asthma Drug Market in China
4. Bridgetech Announces Addition of the Agency for Healthcare Research and Quality as Content Provider in its Development of a Healthcare Web Portal in China
5. China Holdings Appoints Ronald Shon Chairman of Advisory Board to Its Wholly-Owned Subsidiary China Power, Inc.
6. China Bionanometer Industries Corporation Promotes New Cosmetics Product Line in China
7. China Shenghuo Pharmaceutical Holdings, Inc. Begins Full-Scale Launch of 12Ways(R) Chinese Herbal Skin Care Product Line
8. Statement by Mike Leavitt Secretary of Health and Human Services on the United States-China Bilateral Meetings on Food and Drug Safety
9. Supplier Assessments to Help Buyers Identify Reliable China Exporters
10. Study shows lead-based paint problem isnt isolated to China
11. Bracco Announces Initiative to Save Children in China at 2007 Annual Meeting of CGI
Post Your Comments:
(Date:12/1/2015)... ... December 01, 2015 , ... CloudLIMS today announced that ... Business Awards under the New Products and Services category for its innovative product ... management software that helps labs organize data and track samples with storage ...
(Date:12/1/2015)... NY (PRWEB) , ... December 01, 2015 , ... ... non-traumatic limb amputations in the United States. Podiatrists are well aware that psychology-based ... adopt therapeutic behaviors) are often catastrophic contributors to diseases of the diabetic foot. ...
(Date:12/1/2015)... (PRWEB) , ... December 01, 2015 , ... ... their independence is everything. That is why Hollister Incorporated has launched the VaPro ... offer this next product in the VaPro touch free catheter portfolio,” said Michael ...
(Date:12/1/2015)... ... December 01, 2015 , ... ... has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare ... IT Healthcare was recognized as a finalist in the category of Digital Solutions ...
(Date:12/1/2015)... ... 01, 2015 , ... TCS Healthcare Technologies (TCS), a leading ... arenas, is pleased to announce that VIP Care Services, a Caprock Health Group ... ACUITY Complete Care™ Management to back their collaborative catastrophic case management initiatives. ACUITY ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... 1, 2015 /PRNewswire/ -- Royal Philips  ... an X-ray imaging software that produces high-contrast images for ... use a grid, at the 2015 Radiological Society ... SkyFlow is Philips, first digital imaging solution providing grid-like ... improves clinician,s workflow and supports "first-time-right imaging" by decreasing ...
(Date:12/1/2015)... 1, 2015 A federal court has denied the ... a lawsuit filed by the Pharmaceutical Care Management Association (PCMA) ... a new law that forces employers and consumers to pay ... Arkansas must now defend a law that raises ... and CEO Mark Merritt . --> ...
(Date:12/1/2015)... 2015 --> --> ... Market by Type of Drug (Monoclonal Antibodies, Interferon-Alpha, Interleukins, Vaccines, ... Pipeline Analysis - Global Forecast to 2020", published by MarketsandMarkets, ... 73,529.2 Million by 2020 from USD 40,281.6 Million in 2015, ... Browse 37 market data T ...
Breaking Medicine Technology: